Back
Illumina, Inc. 10K Form
Buy
55
ILMN
Illumina, Inc.
Last Price:
$120.00
Seasonality Move:
-3.35%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2026-02-15 | 10K | ILMN/Illumina, Inc. Annual |
| 2026-01-15 | 10K | ILMN/Illumina, Inc. Annual |
| 2025-12-15 | 10K | ILMN/Illumina, Inc. Annual |
| 2025-11-15 | 10K | ILMN/Illumina, Inc. Annual |
| 2025-10-15 | 10K | ILMN/Illumina, Inc. Annual |
| 2025-09-15 | 10K | ILMN/Illumina, Inc. Annual |
Receive ILMN News And Ratings
See the #1 stock for the next 7 days that we like better than ILMN
ILMN Financial Statistics
Sales & Book Value
| Annual Sales: | $4.3B |
|---|---|
| Cash Flow: | $263M |
| Price / Cash Flow: | 20.33 |
| Annual Sales: | $17.80 |
| Price / Book: | 6.74 |
Profitability
| EPS (TTM): | 5.46350 |
|---|---|
| Net Income (TTM): | $850M |
| Gross Margin: | $2.9B |
| Return on Equity: | 35.12% |
| Return on Assets: | 13.54% |
Illumina, Inc. Earnings Forecast
Key Illumina, Inc. Financial Ratios
-
The Gross Profit Margin over the past 28 years for ILMN is 66.69%.
-
The Selling, General & Administrative Expenses for ILMN have been equal to 25.03% of Gross Profit Margin.
-
The Research & Development expenses have been 21.92% of Revenue.
-
The Interest Expense is 11.88% of Operating Income.
-
The Net Earning history of ILMN is 19.59% of Total Revenues.
-
Per Share Earnings over the last 28 years have been positive in 15 years.
Illumina, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | S&P500 |
|---|---|
| Industry: | Life Sciences Tools & Services |
| Sector: | Health Care |
| Current Symbol: | ILMN |
| CUSIP: | 452327 |
| Website: | illumina.com |
Debt
| Debt-to-Equity Ratio: | 0.94 |
|---|---|
| Current Ratio: | 2.08 |
| Quick Ratio: | 1.59 |
Price-to-Earnings
| Trailing P/E Ratio: | 22.02 |
|---|---|
| Forward P/E Ratio: | 20.59 |
ILMN Technical Analysis vs Fundamental Analysis
Buy
55
Illumina, Inc. (ILMN)
is a Buy
Is Illumina, Inc. a Buy or a Sell?
-
Illumina, Inc. stock is rated a BuyThe current Illumina, Inc. [ILMN] share price is $120.00. The Score for ILMN is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.